Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses

The limited efficacy of existing antiviral therapies for influenza – coupled with widespread baseline antiviral resistance – highlights the urgent need for more effective therapy. We describe a triple combination antiviral drug (TCAD) regimen composed of amantadine, oseltamivir, and ribavirin that i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Jack T., Smee, Donald F., Barnard, Dale L., Julander, Justin G., Gross, Matthew, de Jong, Menno D., Went, Gregory T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264642/
https://www.ncbi.nlm.nih.gov/pubmed/22292088
http://dx.doi.org/10.1371/journal.pone.0031006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264642/
https://www.ncbi.nlm.nih.gov/pubmed/22292088
http://dx.doi.org/10.1371/journal.pone.0031006

Ejemplares similares